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Background
Heredity is estimated to cause at least 20% of colorectal
cancer. The hereditary nonpolyposis colorectal cancer
(HNPCC) subset is divided into Lynch syndrome and
familial colorectal cancer type X (FCCTX) based on pre-
sence of mismatch repair gene defects. We addressed the
gene expression signatures in colorectal cancer linked to
Lynch syndrome and FCCTX with the aim to identify
diagnostic discriminators and to map signaling pathways
relevant to hereditary colorectal carcinogenesis.
Patients and methods
RNA extracted from 123 colorectal cancers, including 39
Lynch syndrome tumors, 37 FCCTX tumors and 47
sporadic tumors was analyzed using the whole-genome
c-DNA-mediated annealing, selection, extension, and
ligation (WG-DASL) assay containing 18k genes, where
after key targets were validated by real time quantitative
RT-PCR (qRT-PCR).
Results
Colorectal cancers linked to Lynch syndrome and
FCCTX showed distinct gene expression profiles, which
by significance analysis of microarrays (SAM) differed by
2188 genes. Functional pathways involved were related to
G-protein coupled receptor signaling, oxidative phos-
phorylation, cell cycle function and mitosis and genes
herein proved deregulated using qRT-PCR.
Conclusions
Distinct genetic profiles and deregulation of different
canonical pathways apply to Lynch syndrome and
FCCTX and key targets herein may be relevant to pursue
in relation to refined diagnostic and therapeutic strategies
for hereditary colorectal cancer.
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